| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2012 | A regularly spaced and self-revealing protein ladder for anti-tag Western blot analysis. | Kao, CH; Cheng, CM; Chuang, KH; Chuang, CH; Tzou, SC; Cheng, TC; Hsieh, YC; Liao, KW; Wang, YM; Chang, LS; Roffler, SR; Chen, FM; Cheng, TL | Analytical Biochemistry 431(1), 1-3 | | | |
| 2012 | An activity-based near-infrared glucuronide trapping probe for imaging beta-glucuronidase expression in deep tissues. | Cheng, TC; Roffler, SR; Tzou, SC; Chuang, KH; Su, YC; Chuang, CH; Kao, CH; Chen, CS; Harn, IH; Liu, KY; Cheng, TL; Leu, YL | Journal of the American Chemical Society 134(6), 3103-3110 | | | |
| 2012 | Analytical Measurement of PEGylated Molecules. | Cheng, TL; Chuang, KH; Chen, BM; Roffler, SR | Bioconjugate chemistry 23(5), 881-899 | | | |
| 2017 | Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy. | Su, YC; Burnouf, PA; Chuang, KH; Chen, BM; Cheng, TL; Roffler, SR | NATURE COMMUNICATIONS 8, 15507 | | | |
| 2010 | Development of an universal anti-polyethylene glycol reporter gene for non-invasive imaging of PEGylated probes | Chuang, KH; Wang, HE; Cheng, TC; Tzou, SC; Cheng, CM; Kao, CH; Chuang, CH; Tseng, WL; Hung, WC; Lin, SR; Chen, BM; Roffler, SR; Cheng, TL | JOURNAL OF NUCLEAR MEDICINE 51,933-941 | | | |
| 2015 | Discovery of Specific Inhibitors for Intestinal E. coli beta-Glucuronidase through In Silico Virtual Screening. | Cheng, TC; Chuang, KH; Roffler, SR; Cheng, KW; Leu, YL; Chuang, CH; Huang, CC; Kao, CH; Hsieh, YC; Chang, LS; Cheng, TL; Chen, CS | TheScientificWorldJournal 2015, 740815 | | | |
| 2010 | Endocytosis of PEGylated agents enhances cancer imaging and anticancer efficacy. | Chuang, KH; Wang, HE; Chen, FM; Tzou, SC; Cheng, CM; Chang, YC; Tseng, WL; Shiea, J; Lin, SR; Wang, JY; Chen, BM; Roffler, SR; Cheng, TL | Molecular cancer therapeutics 9(6), 1903-1912 | | | |
| 2009 | Hapten-derivatized nanoparticle targeting and imaging of gene expression by multimodality imaging systems. | Cheng, CM; Chu, PY; Chuang, KH; Roffler, SR; Kao, CH; Tseng, WL; Shiea, J; Chang, WD; Su, YC; Chen, BM; Wang, YM; Cheng, TL | Cancer Gene Therapy 16, 83-90 | | | |
| 2014 | High-throughput sorting of the highest producing cell via a transiently protein-anchored system. | Chuang, KH; Hsieh, YC; Chiang, IS; Chuang, CH; Kao, CH; Cheng, TC; Wang, YT; Lin, WW; Chen, BM; Roffler, SR; Huang, MY; Cheng, TL | PloS one 9(7), e102569 | | | |
| 2011 | In vivo positron emission tomography imaging of protease activity by generation of a hydrophobic product from a non-inhibitory protease substrate. | Cheng, TL; Chuang, CH; Chuang, KH; Wang, HE; Roffler, SR; Shiea, JT; Tzou, SC; Wu, SY; Cheng, TC; Kao, CH; Cheng, CM; Tseng, WL; Hou, MF; Wang, JM | CLINICAL CANCER RESEARCH 18(1), 238-247 | | | |
| 2010 | Measurement of poly(ethylene glycol) by cell-based anti-poly(ethylene glycol) ELISA. | Chuang, KH; Tzou, SC; Cheng, TC; Kao, CH; Tseng, WL; Shiea, J; Liao, KW; Wang, YM; Chang, YC; Huang, BJ; Wu, CJ; Chu, PY; Roffler, SR; Cheng, TL | Analytical chemistry 82(6), 2355-2362 | | | |
| 2016 | Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals. | Chen, BM; Su, YC; Chang, CJ; Burnouf, PA; Chuang, KH; Chen, CH; Cheng, TL; Chen, YT; Wu, JY; Roffler, SR | Analytical chemistry 88(21), 10661-10666 | | | |
| 2009 | Micro-PET imaging of beta-glucuronidase activity by the hydrophobic conversion of a glucuronide probe. | Tzou, SC; Roffler, S; Chuang, KH; Yeh, HP; Kao, CH; Su, YC; Cheng, CM; Tseng, WL; Shiea, J; Harm, IH; Cheng, KW; Chen, BM; Hwang, JJ; Cheng, TL; Wang, HE. | Radiology 252(3), 754-762 | | | |
| 2005 | Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles. | Cheng, TL; Cheng, CM; Chen, BM; Tsao, DA; Chuang, KH; Hsiao, SW; Lin, YH; Roffler, SR | Bioconjugate Chemistry 16, 1225-1231 | | | |
| 2014 | One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles. | Kao, CH; Wang, JY; Chuang, KH; Chuang, CH; Cheng, TC; Hsieh, YC; Tseng, YL; Chen, BM; Roffler, SR; Cheng, TL | Biomaterials 35(37), 9930-9940 | | | |
| 2015 | Selective Delivery of PEGylated Compounds to Tumor Cells by anti-PEG Hybrid Antibodies. | Tung, HY; Su, YC; Chen, BM; Burnouf, PA; Huang, WC; Chuang, KH; Yan, YT; Cheng, TL; Roffler, SR | Molecular cancer therapeutics Epub ahead of print | | | |
| 2010 | Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies. | Su, YC; Chen, BM; Chuang, KH; Cheng, TL; Roffler, SR | Bioconjugate chemistry 21(7), 1264-1270 | | | |
| 2019 | Simply Mixing Poly Protein G with Detection Antibodies Enhances the Detection Limit and Sensitivity of Immunoassays. | Chen, YJ; Chen, M; Cheng, TL; Roffler, SR ; Lin, SY; Hsu, HL; Wang, CH; Chen, CY; Kao, AP; Cheng, JJ; Chuang, KH | Analytical chemistry 91(13), 8310-8317 | | | |
| 2016 | Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles. | Hsieh, YC; Cheng, TC; Wang, HE; Li, JJ; Lin, WW; Huang, CC; Chuang, CH; Wang, YT; Wang, JY; Roffler, SR; Chuang, KH; Cheng, TL | Scientific reports 6, 39119 | | | |
